{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:28:35Z","timestamp":1776472115731,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["ITU20-43"],"award-info":[{"award-number":["ITU20-43"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PRG1428"],"award-info":[{"award-number":["PRG1428"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99664-8","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T05:43:02Z","timestamp":1746250982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of immunological and immunogenetic markers in recent-onset type 1 diabetes among children and adults"],"prefix":"10.1038","volume":"15","author":[{"given":"Kristi","family":"Alnek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aili","family":"Tagoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaja","family":"Metsk\u00fcla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ija","family":"Talja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helis","family":"Janson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maire","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Vorobjova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Oras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Sepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Pruul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koit","family":"Reimand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiia","family":"Simonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr","family":"Peet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Reppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaia","family":"Tammiksaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maire","family":"Lubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaire","family":"Heilman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dclle","family":"Einberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalle","family":"Kisand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margus","family":"Lember","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vallo","family":"Tillmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raivo","family":"Uibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"99664_CR1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo, M. J. & Morgan, N. G. Heterogeneity and endotypes in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 19, 542\u2013554 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"99664_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/jmv.20033","volume":"72","author":"H Viskari","year":"2004","unstructured":"Viskari, H. et al. Relationship between the incidence of type 1 diabetes and enterovirus infections in different european populations: results from the EPIVIR project. J. Med. Virol. 72, 610\u2013617 (2004).","journal-title":"J. Med. Virol."},{"key":"99664_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.933965","author":"P Houeiss","year":"2022","unstructured":"Houeiss, P., Luce, S. & Boitard, C. Environmental triggering of type 1 diabetes autoimmunity. Front. Endocrinol. (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2022.933965 (2022).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"99664_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tem.2021.02.001","volume":"32","author":"SK Patel","year":"2021","unstructured":"Patel, S. K., Ma, C. S., Fourlanos, S. & Greenfield, J. R. Autoantibody-negative type 1 diabetes: A neglected subtype. Trends Endocrinol. Metab. 32, 295\u2013305 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"99664_CR5","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1210\/jc.2016-2478","volume":"101","author":"JW Hughes","year":"2016","unstructured":"Hughes, J. W. et al. Autoimmune diseases in children and adults with type 1 diabetes from the t1d exchange clinic registry. J. Clin. Endocrinol. Metab. 101, 4931\u20134937 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"99664_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/pedi.12597","volume":"19","author":"MJ Redondo","year":"2018","unstructured":"Redondo, M. J., Steck, A. K. & Pugliese, A. Genetics of type 1 diabetes. Pediatr. Diabetes 19, 346\u2013353 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"99664_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/pedi.12327","volume":"17","author":"J Ilonen","year":"2016","unstructured":"Ilonen, J. et al. Genetic susceptibility to type 1 diabetes in childhood\u2014Estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity. Pediatr. Diabetes 17, 8\u201316 (2016).","journal-title":"Pediatr. Diabetes"},{"key":"99664_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/ahg.12016","volume":"77","author":"C Xuan","year":"2013","unstructured":"Xuan, C. et al. PTPN22 gene polymorphism (C1858T) Is associated with susceptibility to type 1 diabetes: A meta-analysis of 19,495 cases and 25,341 controls. Ann. Hum. Genet. 77, 191\u2013203 (2013).","journal-title":"Ann. Hum. Genet."},{"key":"99664_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.diabres.2010.11.012","volume":"91","author":"K Xu","year":"2011","unstructured":"Xu, K. et al. Association between rs13266634 C\/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes\u2013a meta-analysis. Diabetes Res. Clin. Pract. 91, 195\u2013202 (2011).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"99664_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/08916934.2013.796937","volume":"46","author":"H Cen","year":"2013","unstructured":"Cen, H. et al. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: A meta-analysis. Autoimmunity 46, 455\u2013462 (2013).","journal-title":"Autoimmunity"},{"key":"99664_CR11","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.4238\/2013.December.6.1","volume":"12","author":"J Liu","year":"2013","unstructured":"Liu, J. & Zhang, H. Association between the Rs3087243 polymorphism and risk for diabetes: A meta-analysis. Genet. Mol. Res. 12, 6344\u20136350 (2013).","journal-title":"Genet. Mol. Res."},{"key":"99664_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05724-3","author":"S Bruzzaniti","year":"2022","unstructured":"Bruzzaniti, S. et al. High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease. Diabetologia https:\/\/doi.org\/10.1007\/s00125-022-05724-3 (2022).","journal-title":"Diabetologia"},{"key":"99664_CR13","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.ebiom.2023.104625","volume":"92","author":"T Suomi","year":"2023","unstructured":"Suomi, T. et al. Gene expression signature predicts rate of type 1 diabetes progression. EBioMedicine 92, 1615\u20131622 (2023).","journal-title":"EBioMedicine"},{"key":"99664_CR14","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00125-013-2896-y","volume":"56","author":"P Achenbach","year":"2013","unstructured":"Achenbach, P. et al. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia 56, 1615\u20131622 (2013).","journal-title":"Diabetologia"},{"key":"99664_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/dme.12048","volume":"30","author":"SR Merger","year":"2013","unstructured":"Merger, S. R., Leslie, R. D. & Boehm, B. O. The broad clinical phenotype of Type 1 diabetes at presentation. Diabet. Med. 30, 170\u2013178 (2013).","journal-title":"Diabet. Med."},{"key":"99664_CR16","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s00125-022-05769-4","volume":"65","author":"AJ Deutsch","year":"2022","unstructured":"Deutsch, A. J., Ahlqvist, E. & Udler, M. S. Phenotypic and genetic classification of diabetes. Diabetologia 65, 1758\u20131769 (2022).","journal-title":"Diabetologia"},{"key":"99664_CR17","doi-asserted-by":"publisher","first-page":"e020904","DOI":"10.1136\/bmjopen-2017-020904","volume":"8","author":"V Bravis","year":"2018","unstructured":"Bravis, V. et al. Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort. BMJ Open 8, e020904 (2018).","journal-title":"BMJ Open"},{"key":"99664_CR18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1210\/clinem\/dgz296","volume":"105","author":"MJ Redondo","year":"2020","unstructured":"Redondo, M. J. et al. Single islet autoantibody at diagnosis of clinical type 1 diabetes is associated with older age and insulin resistance. J. Clin. Endocrinol. Metab. 105, 1629\u20131249 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"99664_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00592-017-1091-x","volume":"55","author":"E Niechcia\u0142","year":"2018","unstructured":"Niechcia\u0142, E. et al. Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes. Acta Diabetol. 55, 287\u2013294 (2018).","journal-title":"Acta Diabetol."},{"key":"99664_CR20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/dmrr.2440","volume":"29","author":"KM Salonen","year":"2013","unstructured":"Salonen, K. M. et al. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes. Diabetes. Metab. Res. Rev. 29, 646\u2013654 (2013).","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"99664_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05514-3","author":"JP Krischer","year":"2021","unstructured":"Krischer, J. P. et al. Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study. Diabetologia https:\/\/doi.org\/10.1007\/s00125-021-05514-3 (2021).","journal-title":"Diabetologia"},{"key":"99664_CR22","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.2337\/db11-0364","volume":"60","author":"JMM Howson","year":"2011","unstructured":"Howson, J. M. M. et al. Genetic analysis of adult-onset autoimmune diabetes. Diabetes 60, 2645\u20132653 (2011).","journal-title":"Diabetes"},{"key":"99664_CR23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/pedi.13073","volume":"21","author":"M-L Mikk","year":"2020","unstructured":"Mikk, M.-L. et al. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity. Pediatr. Diabetes 21, 1218\u20131226 (2020).","journal-title":"Pediatr. Diabetes"},{"key":"99664_CR24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/apa.16621","volume":"112","author":"V Kielev\u00e4inen","year":"2023","unstructured":"Kielev\u00e4inen, V. et al. Increased HLA class II risk is associated with a more aggressive presentation of clinical type 1 diabetes. Acta Paediatr. 112, 522\u2013528 (2023).","journal-title":"Acta Paediatr."},{"key":"99664_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.706964","author":"K Wang","year":"2021","unstructured":"Wang, K. et al. Association between enterovirus infection and type 1 diabetes risk: A meta-analysis of 38 case-control studies. Front. Endocrinol. (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.706964 (2021).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"99664_CR26","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2337\/dc23-0124","volume":"46","author":"J Tojjar","year":"2023","unstructured":"Tojjar, J. et al. Sex Differences in age of diagnosis, HLA genotype, and autoantibody profile in children with type 1 diabetes. Diabetes Care 46, 1993\u20131996 (2023).","journal-title":"Diabetes Care"},{"key":"99664_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/(SICI)1520-7560(200001\/02)16:1<8::AID-DMRR77>3.0.CO;2-T","volume":"16","author":"C Tiberti","year":"2000","unstructured":"Tiberti, C. et al. Autoantibody negative new onset Type 1 diabetic patients lacking high risk HLA alleles in a Caucasian population: Are these Type 1b diabetes cases?. Diabetes. Metab. Res. Rev. 16, 8\u201314 (2000).","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"99664_CR28","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2337\/diacare.27.5.1108","volume":"27","author":"E Aguilera","year":"2004","unstructured":"Aguilera, E. et al. Adult-onset atypical (type 1) diabetes: Additional insights and differences with type 1A diabetes in a European Mediterranean population. Diabetes Care 27, 1108\u20131114 (2004).","journal-title":"Diabetes Care"},{"key":"99664_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2337\/dbi18-0066","volume":"68","author":"AW Purcell","year":"2019","unstructured":"Purcell, A. W., Sechi, S. & DiLorenzo, T. P. The evolving landscape of autoantigen discovery and characterization in type 1 diabetes. Diabetes 68, 879\u2013886 (2019).","journal-title":"Diabetes"},{"key":"99664_CR30","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.2337\/db13-1566","volume":"63","author":"BK Koo","year":"2014","unstructured":"Koo, B. K. et al. Identification of novel autoantibodies in type 1 diabetic patients using a high-density protein microarray. Diabetes 63, 3022\u20133032 (2014).","journal-title":"Diabetes"},{"key":"99664_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/dc19-0747","volume":"43","author":"A Carlsson","year":"2020","unstructured":"Carlsson, A. et al. Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: Lessons from a 5-year pediatric Swedish national cohort study. Diabetes Care 43, 82\u201389 (2020).","journal-title":"Diabetes Care"},{"key":"99664_CR32","unstructured":"University of Exeter Medical School and the Royal Devon and Exeter NHS Foundation Trust (V1.0.0). Exeter Diabetes App. https:\/\/www.diabetesgenes.org\/exeter-diabetes-app\/."},{"key":"99664_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dc19-0880","volume":"43","author":"M Battaglia","year":"2020","unstructured":"Battaglia, M. et al. Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care 43, 5\u201312 (2020).","journal-title":"Diabetes Care"},{"key":"99664_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112858","author":"BO Roep","year":"2023","unstructured":"Roep, B. O. The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1112858 (2023).","journal-title":"Front. Immunol."},{"key":"99664_CR35","doi-asserted-by":"publisher","DOI":"10.2337\/DC22-2200","author":"WE Russell","year":"2023","unstructured":"Russell, W. E. et al. Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: A randomized, double-masked, Controlled Trial. Diabetes Care https:\/\/doi.org\/10.2337\/DC22-2200 (2023).","journal-title":"Diabetes Care"},{"key":"99664_CR36","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes Sec 2. In standards of medical care in diabetes\u20142015. Diabetes Care 38, S8\u2013S16 (2015).","journal-title":"Diabetes Care"},{"key":"99664_CR37","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.humimm.2013.07.007","volume":"74","author":"K Pruul","year":"2013","unstructured":"Pruul, K. et al. Expression of B7 and CD28 family genes in newly diagnosed type 1 diabetes. Hum. Immunol. 74, 1251\u20131257 (2013).","journal-title":"Hum. Immunol."},{"key":"99664_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.mce.2015.05.012","volume":"412","author":"K Pruul","year":"2015","unstructured":"Pruul, K. et al. Differences in B7 and CD28 family gene expression in the peripheral blood between newly diagnosed young-onset and adult-onset type 1 diabetes patients. Mol. Cell. Endocrinol. 412, 265\u2013271 (2015).","journal-title":"Mol. Cell. Endocrinol."},{"key":"99664_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00592-017-1082-y","volume":"55","author":"D Liberati","year":"2018","unstructured":"Liberati, D. et al. A novel LIPS assay for insulin autoantibodies. Acta Diabetol. 55, 263\u2013270 (2018).","journal-title":"Acta Diabetol."},{"key":"99664_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/S00125-023-05877-9\/FIGURES\/9","author":"I Marzinotto","year":"2023","unstructured":"Marzinotto, I. et al. Islet autoantibody standardization program: Interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops. Diabetologia https:\/\/doi.org\/10.1007\/S00125-023-05877-9\/FIGURES\/9 (2023).","journal-title":"Diabetologia"},{"key":"99664_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.humimm.2013.09.008","volume":"75","author":"ML Mikk","year":"2014","unstructured":"Mikk, M. L. et al. The HLA-B*39 allele increases type 1 diabetes risk conferred by HLA-DRB1*04:04-DQB1*03:02 and HLA-DRB1*08-DQB1*04 class II haplotypes. Hum. Immunol. 75, 65\u201370 (2014).","journal-title":"Hum. Immunol."},{"key":"99664_CR42","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/dia.2007.0229","volume":"9","author":"M Kiviniemi","year":"2007","unstructured":"Kiviniemi, M. et al. A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: An application for the TEDDY (The environmental determinants of diabetes in the young) study. Diabetes Technol. Ther. 9, 460\u2013472 (2007).","journal-title":"Diabetes Technol. Ther."},{"key":"99664_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cca.2009.03.036","volume":"403","author":"K Douroudis","year":"2009","unstructured":"Douroudis, K., Prans, E., Kisand, K., Nemvalts, V. & Uibo, R. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms are associated with latent autoimmune diabetes in adults. Clin. Chim. Acta. 403, 226\u2013228 (2009).","journal-title":"Clin. Chim. Acta."},{"key":"99664_CR44","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00228-010-0882-6","volume":"66","author":"Q Huang","year":"2010","unstructured":"Huang, Q. et al. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients. Eur. J. Clin. Pharmacol. 66, 1207\u20131215 (2010).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"99664_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99664-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99664-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99664-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T05:43:05Z","timestamp":1746250985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99664-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99664"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99664-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Research Ethics Committee of the University of Tartu (protocols 163\/T-6 from 24.09.2007 and 275\/M\/15 from 20.11.2017) and performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects and their legal guardian(s).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"15491"}}